A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19

BACKGROUND: Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. METHODS: We conducted a randomized, double-blind, controlled trial among adults hospitalized with severe an...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Invest
मुख्य लेखकों: O’Donnell, Max R., Grinsztejn, Beatriz, Cummings, Matthew J., Justman, Jessica E., Lamb, Matthew R., Eckhardt, Christina M., Philip, Neena M., Cheung, Ying Kuen, Gupta, Vinay, João, Esau, Pilotto, Jose Henrique, Diniz, Maria Pia, Cardoso, Sandra Wagner, Abrams, Darryl, Rajagopalan, Kartik N., Borden, Sarah E., Wolf, Allison, Sidi, Leon Claude, Vizzoni, Alexandre, Veloso, Valdilea G., Bitan, Zachary C., Scotto, Dawn E., Meyer, Benjamin J., Jacobson, Samuel D., Kantor, Alex, Mishra, Nischay, Chauhan, Lokendra V., Stone, Elizabeth F., Dei Zotti, Flavia, La Carpia, Francesca, Hudson, Krystalyn E., Ferrara, Stephen A., Schwartz, Joseph, Stotler, Brie A., Lin, Wen-Hsuan W., Wontakal, Sandeep N., Shaz, Beth, Briese, Thomas, Hod, Eldad A., Spitalnik, Steven L., Eisenberger, Andrew, Lipkin, Walter I.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Clinical Investigation 2021
विषय:
Clinical Medicine
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8245169/
https://ncbi.nlm.nih.gov/pubmed/33974559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI150646
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन